One significant benefit is their ability to regulate blood sugar levels in individuals with type 2 diabetes
Patients with certain GLP1R variants, for example, may achieve excellent results at lower doses, aligning with the PlexusDx principle that 'your dose may need to go up, your price won't.' Understanding your genetic predisposition removes guesswork and accelerates your path to the right tirzepatide dose for sustainable weight loss
The 5 mg dose is the lowest therapeutic dose tested, and it produced clinically significant results in most participants
In addition, GLP-1 signaling score exhibited close association with tumor mutation burden, microsatellite instability and immunotherapy response in patients with cancer
Emerging evidence points to broad therapeutic potential across metabolic regulation, cardiovascular and hepatic function, neurodegenerative processes, and behavioural health